Condition | Clinical manifestations | Frequency | Management | Comment |
---|---|---|---|---|
Hypogonadotropic hypogonadism | Genital hypoplasia (micropenis, cryptorchidism, hypoplastic labia/clitoris), pubertal delay/arrest | 50-70% | Testosterone/Oestrogen replacement therapy | HHG in association with anosmia overlaps with Kallmann syndrome [15] |
Hypothyroidism | Jaundice, lethargy and feeding difficulties (newborn), failure to thrive | 15-20% | Thyroxine replacement therapy | Routine biochemical assessment of thyroid function not necessary, reserved for patients with clinical features of hypothyroidism [16] |
GH deficiency | Poor growth, short stature, hypoglycemia | 9% | GH replacement therapy | Short stature in CS usually not solely due to hormone deficiency [17] |
Secondary hypoadrenalism | Adrenal crisis with hypoglycemia and hyponatremia | n.a | Hydrocortisone | |
Congenital hypopituitarism | Multiple pituitary hormone deficiencies | n.a | Hormone replacement therapy | Associated with structural anomalies of the anterior or posterior pituitary gland [11] |
Hypoparathyroidism | Hypocalcemia | n.a. | Activated vitamin D (calcitriol) and calcium supplements | HP, also seen in association with immunological anomalies, overlaps with Di George syndrome [18] |
Hyperinsulinemic hypoglycemia | Hypoglycemia | n.a | Diazoxide | Reported in a 2-year-old Japanese male patient by Sekiguchi et al. [7] |